Effect of nasal salmon calcitonin on bone remodeling and bone mass in postmenopausal osteoporosis
- 29 February 1996
- Vol. 18 (2) , 207-212
- https://doi.org/10.1016/8756-3282(95)00447-5
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Long-term (3 years) prevention of trabecular postmenopausal bone loss with low-dose intermittent nasal salmon calcitoninJournal of Bone and Mineral Research, 1994
- Bone remodeling during calcitonin excess: Reconstruction of the remodeling sequence in medullary thyroid carcinomaBone, 1993
- Reconstruction of the formative site in trabecular bone by a new, quick, and easy methodBone, 1992
- Effect of salcatonin given intranasally on bone mass and fracture rates in established osteoporosis: a dose-response study.BMJ, 1992
- Effect of salcatonin given intranasally on early postmenopausal bone loss.BMJ, 1989
- NASAL CALCITONIN FOR TREATMENT OF ESTABLISHED OSTEOPOROSISClinical Endocrinology, 1989
- Reconstruction of the resorptive site in iliac trabecular bone: A kinetic model for bone resorption in 20 normal individualsMetabolic Bone Disease and Related Research, 1984
- Tetracycline double-labeling of iliac trabecular bone in 41 normal adultsCalcified Tissue International, 1978
- Tetracycline-based histological analysis of bone remodelingCalcified Tissue International, 1969
- Thyrocalcitonin: Inhibitor of Bone Resorption in Tissue CultureScience, 1965